Hospira
From Wikipedia, the free encyclopedia
| Hospira, Inc. | |
|---|---|
 |
|
| Type | Public (NYSE: HSP) |
| Founded | Lake Forest, Illinois (May 3, 2004) |
| Headquarters | Lake Forest, Illinois, United States |
| Website | www.hospira.com |
Hospira, Inc. is a pharmaceutical and drug delivery company. It has approximately 16,000 employees and 19 manufacturing facilities worldwide and is headquartered north of Chicago in Lake Forest, Illinois. Hospira acquired Mayne Pharma (an Australian generics specialist oncology drug maker) on February 2, 2007 for a reported $2.6 billion and became the largest generic injectables company in the world. Hospira also produces a broad line of generic acute-care injectables to address the high cost of proprietary pharmaceuticals. In addition it provides medication management and infusion therapy.
[edit] History
Spun off from Abbott Laboratories on May 3, 2004......
[edit] Products
Some of the key products produced by Hospira:
[edit] External links
 |
This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it. |
